Trypanosomiasis
Showing 1 - 25 of 49
Assessment of Recombinant HAT-RDT Specificity
Recruiting
- Human African Trypanosomiasis
-
Kinshasa, Congo, The Democratic Republic of theProgramme National de Lutte contre la Trypanosomiase Humaine Afr
Nov 24, 2022
Trypanosomiasis, African Trial in Kuala Lumpur (Acoziborole, Midazolam, Dextromethorphan)
Completed
- Trypanosomiasis, African
- Acoziborole
- +2 more
-
Kuala Lumpur, MalaysiaClinical Research Center (CRC) Ampang Hospital
Jul 7, 2023
Sleeping Sickness, Trypanosomiasis, African Trial (Screen&treat)
Not yet recruiting
- Sleeping Sickness
- Trypanosomiasis, African
- Screen&treat
- (no location specified)
Nov 30, 2022
A Retrospective Analysis of Suramin Treatment for Stage 1 TBR
Completed
- Trypanosoma Brucei Rhodesiense; Infection
-
Tarrytown, New YorkPaxMedica
Sep 27, 2023
Human African Trypanosomiasis, Sleeping Sickness, Trypanosoma Brucei Gambiense; Infection Trial in Bonon, Dubréka (Serological
Recruiting
- Human African Trypanosomiasis
- +3 more
- Serological field test for HAT
- +3 more
-
Bonon, Côte D'Ivoire
- +1 more
Jul 15, 2022
Human African Trypanosomiasis, Sleeping Sickness, Trypanosoma Brucei Gambiense; Infection Trial in Bobo Dioulasso, Kinshasa,
Completed
- Human African Trypanosomiasis
- +5 more
- Rapid diagnostic test (RDT); Serological and molecular tests on DBS
-
Bobo Dioulasso, Burkina Faso
- +2 more
Apr 14, 2022
Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection, Sleeping Sickness Trial in Congo, The Democratic Republic of
Recruiting
- Trypanosomiasis, African
- +2 more
-
Mbuji-Mayi, Kasai-Oriental, Congo, The Democratic Republic of the
- +4 more
Jul 18, 2022
Trypanosomiasis, African, Sleeping Sickness, Trypanosomiasis; Gambian Trial in Congo, The Democratic Republic of the, Guinea
Completed
- Trypanosomiasis, African
- +2 more
-
Mbuji-Mayi, Kasaï Oriental, Congo, The Democratic Republic of the
- +7 more
Oct 8, 2021
Trypanosomiasis, African, Gambiense Trypanosomiasis, Sleeping Sickness Trial in Congo, The Democratic Republic of the, Guinea
Completed
- Trypanosomiasis, African
- +2 more
- Acoziborole (SCYX-7158)
-
Nkara, Bandundu, Congo, The Democratic Republic of the
- +11 more
Jan 17, 2022
Trypanosoma Brucei Rhodesiense; Infection Trial in Rumphi, Lwala (Fexinidazole)
Recruiting
- Trypanosoma Brucei Rhodesiense; Infection
-
Rumphi, Malawi
- +1 more
Aug 27, 2021
Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection, Sleeping Sickness Trial in Congo, The Democratic Republic of
Recruiting
- Trypanosomiasis, African
- +2 more
- Acoziborole
- Placebo
-
Mbuji-Mayi, Kasai-Oriental, Congo, The Democratic Republic of the
- +3 more
Feb 15, 2022
African Trypanosomiasis, African; Trypanosomiasis, West, Sleeping Sickness; West African Trial in Kinshasa (RNA and neopterin
Completed
- African Trypanosomiasis
- +3 more
- RNA and neopterin detection
-
Kinshasa, Congo, The Democratic Republic of theProgramme Nationale de Lutte contre la trypanosomiase humaine Af
Feb 18, 2021
African Trypanosomiases, West African; Trypanosomiasis, Sleeping Sickness; West African Trial in Kinshasa, Bouaké, Conakry
Completed
- African Trypanosomiases
- +3 more
- Rapid diagnostic test (RDT)
- Serological and molecular tests on DBS
-
Kinshasa, Congo, The Democratic Republic of the
- +2 more
Feb 18, 2021
Trypanosomiases, African Trial in Nottingham ([14C]-acoziborole capsule, 240 mg containing NMT 9.25 kBq (250 nCi) 14C)
Completed
- Trypanosomiases, African
- [14C]-acoziborole capsule, 240 mg containing NMT 9.25 kBq (250 nCi) 14C
-
Nottingham, United KingdomQuotient Sciences
Apr 26, 2021
Human African Trypanosomiasis (HAT) Trial in Kinshasa (Fexinidazole)
Completed
- Human African Trypanosomiasis (HAT)
-
Kinshasa, Congo, The Democratic Republic of the(unnamed)
Jun 23, 2020
Human African Trypanosomiasis (HAT) Trial in Kinshasa (fexinidazole)
Completed
- Human African Trypanosomiasis (HAT)
-
Kinshasa, Congo, The Democratic Republic of the(unnamed)
Jun 23, 2020
RDT to Screen for Gambiense HAT and Diagnose P. Falciparum
Unknown status
- Human African Trypanosomiasis
- No intervention
- (no location specified)
Feb 13, 2019
Chagas Disease, Trypanosomiasis, Heart Disease Trial in Worldwide (Benznidazole, Placebo)
Completed
- Chagas Disease
- +2 more
- Benznidazole
- Placebo
-
Ciudad Autónoma de Buenos Aires, Apital Federal, Argentina
- +46 more
Feb 27, 2020
Chagas' Disease (Chronic) Nos Trial in Barcelona (Fexinidazole, Placebo Oral Tablet)
Completed
- Chagas' Disease (Chronic) Nos
- Fexinidazole
- Placebo Oral Tablet
-
Barcelona, Catalunia, SpainHospital Clinic
Sep 21, 2020
Human African Trypanosomiasis (HAT), Sleeping Sickness Trial in Central African Republic, Congo, Congo, The Democratic Republic
Completed
- Human African Trypanosomiasis (HAT)
- Sleeping Sickness
- Fexinidazole
- +2 more
-
Batangafo, Central African Republic
- +9 more
Feb 17, 2018
COVID-19 Trial in Zapopan (Ivermectin, Placebo)
Completed
- COVID-19
- Ivermectin
- Placebo
-
Zapopan, Jalisco, MexicoInvestigacion Biomédica para el Desarrollo de Fármacos S.A. de C
May 19, 2021
Chagas Disease Trial in Bucaramanga (Nifurtimox, Benznidazole, Placebo)
Unknown status
- Chagas Disease
- Nifurtimox
- +2 more
-
Bucaramanga, Santander, ColombiaFundación Oftalmológica de Santander - Clínica Ardila Lulle (FOS
Jul 18, 2017
Human African Trypanosomiasis Trial in Paris (Fexinidazole/Placebo)
Completed
- Human African Trypanosomiasis
- Fexinidazole/Placebo
-
Paris, FranceSGS Aster
Apr 5, 2017
Trypanosomiasis, African Trial in Paris (Tablets Fexinidazole, Placebo)
Terminated
- Trypanosomiasis, African
- Tablets Fexinidazole
- Placebo
-
Paris, FranceSGS Life Sciences
Mar 29, 2017
Trachoma Trial in Addis Ababa, London (IR3535, Permethrin lower dose, Permethrin higher dose)
Completed
- Trachoma
- IR3535
- +2 more
-
Addis Ababa, Ethiopia
- +1 more
Apr 7, 2020